Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial

JAMA

Volumn 308, Issue 7, 2012, Pages 690-699

  Mills, Katherine L ^a   Teesson, Maree ^a   Back, Sudie E ^c   Brady, Kathleen T ^c   Baker, Amanda L ^d   Hopwood, Sally ^b   Sannibale, Claudia ^a   Barrett, Emma L ^a   Merz, Sabine ^a   Rosenfeld, Julia ^a   Ewer, Philippa L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; AUSTRALIA; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; COGNITIVE THERAPY; COMMUNITY BASED REHABILITATION; COMORBIDITY; COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; CONCURRENT TREATMENT OF PTSD AND SUBSTANCE USE DISORDER USING PROLONGED EXPOSURE; CONTROLLED STUDY; DEPRESSION; DETOXIFICATION; DISEASE SEVERITY; DSM-IV; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; ADDICTION; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUNSELING; HOSPITALIZATION; MULTIMODALITY CANCER THERAPY; OPIATE SUBSTITUTION TREATMENT; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; COUNSELING; FEMALE; HUMANS; IMPLOSIVE THERAPY; MALE; OPIATE SUBSTITUTION TREATMENT; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865095447     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.9071     Document Type: Article

References (40)

1. Foa EB, Keane TM, Friedman MJ, Cohen JA. Effective Treatments for PTSD: Practice Guidelines From the International Society for Traumatic Stress Studies. 2nd ed. New York, NY: Guilford Press; 2009.
2. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2000;61(suppl 5):60-66.
3. Institute of Medicine. Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC: National Academies Press; 2008.
4. Cahill SP, Rothbaum BO, Resick PA, Follette VM. Cognitive-Behavioral Therapy for Adults: Effective Treatments for PTSD: Practice Guidelines From the International Society for Traumatic Stress Studies. 2nd ed. New York, NY: Guilford Press; 2009:139-222.
5. Mills KL, Teesson M, Ross J, Peters L. Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Well-Being. Am J Psychiatry. 2006;163(4):652-658.
6. Dore G, Mills K, Murray R, Teesson M, Farrugia P. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Rev. 2012;31(3):294-302.
7. Krystal JH, Rosenheck RA, Cramer JA, et al; Veterans Affairs Cooperative Study No. 504 Group. Adjunctive risperidone treatment for antidepressant- resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502.
8. Pietrzak RH, Goldstein RB, Southwick SM, Grant BF. Prevalence and axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anxiety Disord. 2011;25(3):456-465.
9. Pitman RK, Altman B, Greenwald E, et al. Psychiatric complications during flooding therapy for posttraumatic stress disorder. J Clin Psychiatry. 1991;52(1):17-20.
10. Becker CB, Zayfert C, Anderson E. A survey of psychologists'attitudes towards and utilization of exposure therapy for PTSD. Behav Res Ther. 2004;42(3):277-292.
11. Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162(2):214-227.
12. Triffleman E. Gender differences in a controlled pilot study of psychosocial treatments in substance dependent patients with post-traumatic stress disorder: design considerations and outcomes. Alcohol Treat Q. 2000;18(3):113-126.
13. Brady KT, Dansky BS, Back SE, Foa EB, Carroll KM. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat. 2001;21(1):47-54.
14. Najavits LM, Schmitz M, Gotthardt S, Weiss RD. Seeking Safety plus Exposure Therapy: an outcome study on dual-diagnosis men. J Psychoactive Drugs. 2005;37(4):425-435.
15. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75-90.
16. Kessler RC, Ustün TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93-121.
17. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87(5):733-742.
18. World Health Organisation. Composite International Diagnostic Interview (CIDI) Core Version 2.1, 12 Month Version.Geneva, Switzerland: World Health Organisation; 1997.
19. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corp; 1996.
20. Spielberger CD. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
21. Loranger AW, Janca A, Sartorius N. Assessment and Diagnosis of Personality Disorders. Cambridge, United Kingdom: Cambridge University Press; 1997.
22. Back SE, Dansky BS, Carroll KM, Foa EB, Brady KT. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures. J Subst Abuse Treat. 2001;21(1):35-45.
23. Carroll KM. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: US Dept of Health and Human Services, National Institute on Drug Abuse; 1998.
24. Foa EB, Rothbaum BO. Treating the Trauma of Rape: Cognitive-Behavioral Therapy for PTSD. New York, NY: Guilford Press; 1998.
25. Baker A, Kay-Lambkin F, Lee NK, Claire M, Jenner L. A Brief Cognitive Behavioural Intervention for Regular Amphetamine Users. Canberra: Australian Government Department of Health and Ageing; 2003.
26. Weathers FW, Keane TM, Davidson JRT. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety. 2001;13(3):132-156.
27. McBride O, Adamson G, Bunting BP, McCann S. Assessing the general health of diagnostic orphans using the Short Form Health Survey (SF-12v2): a latent variable modelling approach. Alcohol Alcohol. 2009;44(1):67-76.
28. Preuss UW, Schuckit MA, Smith TL, et al. Predictors and correlates of suicide attempts over 5 years in 1,237 alcohol-dependent men and women. Am J Psychiatry. 2003;160(1):56-63.
29. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147-177.
30. Zhang P. Multiple imputation: theory and method. Int Stat Rev. 2003;71(3):581-592.
31. Back SE, Brady KT, Sonne SC, Verduin ML. Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis. 2006;194(9):690-696.
32. Hien DA, Jiang H, Campbell ANC, et al. Do treatment improvements in PTSD severity affect substance use outcomes? a secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry. 2010;167(1):95-101.
33. Beynon CM, Bellis MA, McVeigh J. Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England.BMCPublic Health. 2006;6:205.
34. Tate SR, Mrnak-Meyer J, Shriver CL, Atkinson JH, Robinson SK, Brown SA. Predictors of treatment retention for substance-dependent adults with cooccurring depression. Am J Addict. 2011;20(4):357-365.
35. Craske MG, Stein MB, Sullivan G, et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry. 2011;68(4):378-388.
36. Mills KL, Lynskey M, Teesson M, Ross J, Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and correlates. Drug Alcohol Depend. 2005;77(3):243-249.
37. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253-268.
38. Sherman MF, Bigelow GE. Validity of patients' self-reported drug use as a function of treatment status. Drug Alcohol Depend. 1992;30(1):1-11.
39. Calhoun PS, Sampson WS, Bosworth HB, et al. Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder. J Consult Clin Psychol. 2000;68(5):923-927.
40. Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry. 1998;155(1):127-128.